AzTrials
AzTrials

ObesityNCT02828228

Vitamin D Supplementation in Vitamin D Deficient Obese Children During Weight-loss Program

A study testing Vitamin D 1200 IU in people with Obesity, run by University Clinical Centre, Gdansk at 1 site in Poland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

1. Analyze the influence of vitamin D supplementation in obese children during weight-loss program on BMI, body composition and bone mineral density. 2. Analyze the influence of vitamin D supplementation on the risk profile of obesity-related complications, namely impaired tolerance of glucose, insulin resistance… Read more about this study

Who is it for?
Ages 6 to 14 years
Conditions the study is for
Obesity
What is being tested?
Vitamin D 1200 IU
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
200 participants
Where
1 sitePoland
Study dates
Feb 2016to Feb 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • overweight (BMI between the 85th and 95th percentile) or obesity (BMI > 95th percentile), identified on the basis of anthropometric parameters
  • blood concentration of 25(OH)D3 < 30 ng/ml
  • written consent of legal guardians

Who cannot join

  • Chronic conditions (asthma or allergies, inflammatory diseases of connective tissue, gastrointestinal disorders, diseases of kidneys and liver, disorders of bone metabolism)
  • Contraindications to administration of vitamin D
  • Administration of any preparation containing vitamin D, calcium, or steroid hormones during 3 months preceding the study

Trial locations and contacts

1 site in 1 country.

Magdalena Słominska-Frączek, MD, contact

694844420

fraczek@gumed.edu.pl

Agnieszka Jankowska, MD, PhD contact

48606335246

ajankowska@gumed.edu.pl

Poland1 site, 1 recruiting
  • IUCCGdansk

    Gdansk, Pomeranian Voivodeship, 80-210

    Agnieszka Szlagatys, MD, PhD, 601622894, aga1@gumed.edu.pl

    Recruiting

Other trials in Poland

About this study

Official title: Long-term Effects of Vitamin D Supplementation in Vitamin D Deficient Obese Children During Integrated Weight-loss Program - a Double Blind Placebo Controlled Study

  1. Analyze the influence of vitamin D supplementation in obese children during weight-loss program on BMI, body composition and bone mineral density.
  2. Analyze the influence of vitamin D supplementation on the risk profile of obesity-related complications, namely impaired tolerance of glucose, insulin resistance, dyslipidemia and arterial hypertension, in obese children participating in weight-loss program.
  3. Analyze the prevalence of vitamin D deficiency among obese children.
  4. Analyze the risk factors of vitamin D deficiency in obese children (age, gender, pubertal status).
Read the detailed description

The study will be conducted as a continuation and development of "6-10-14 for Health" program. The first phase of the program, financed by the municipality of Gdansk, was conducted in 2011-2013. The program comprised of screening and survey conducted among all 6-, 10- and 14-year-old children attending primary and grammar schools. A total of 18 162 children (including 7 448 6-year olds, 6 720 10-year olds and 3 994 14-year olds) were examined. A group of children with risk factors of civilization-related diseases (overweight and obesity defined according to BMI percentile charts. was identified on the basis of the screening. This group included 2 798 (16.32%) children, among them 9.17% of 6-years of age, 19.30% of 10-years and 20.48% of 14-years). All these children were qualified to intervention and education program. A total of 1 627 children qualified on the basis of screening eventually took part in the first edition of the program.

A total of 4 meetings with participating children and their caregivers were scheduled during the 12-month-long education and intervention program: at enrollment, and 3, 6 and 12 months thereafter. The meetings had form of individual consultations with various specialists. The first visit included complex medical examination, discussion on a health status of a child, interpretation of laboratory findings, and consultations with dietician, psychologist and physical education specialist. After consulting all the specialists involved in the program, individual protocol of health intervention was developed for every child. The objectives of the intervention included modification of diet, increasing health activity level and strengthening of health-seeking behaviors of child's family members. Adherence to the protocol and achieved results were evaluated during follow-up meetings with the specialists, and constituted the basis for development of individualized intervention plans for subsequent months.

The preliminary evaluation of the program effects was conducted in the group of 300 participants. The average percentile of BMI at enrollment to the program and after 12 months of participation amounted to 92.96 and 88.83, respectively. Participation in the program was reflected by a significant decrease in BMI percentile (p=0.0001), as well as by a significant drop off in fat mass content measured by bioelectrical impedance, from 39.0% to 31.4% (p=0.0001).

On the basis of these findings, the municipality of Gdansk decided to support the program for 2014-2016.

The experiment will follow a pattern of double blind randomized study. The enrolled subjects will be randomly assigned to one of the two groups:

Group 1 - weight-loss program for 52 weeks + vitamin D 1200 (IU) daily for 26 weeks Group 2 - weight-loss program for 52 weeks +placebo daily for 26 weeks

Visit I: enrollment:

  • medical history, physical examination
  • interpretation of laboratory findings (the tests conducted during screening + concentration of vitamin D),
  • anthropometric evaluation and analysis of body composition (bioimpedance method)
  • consultation of dietician, psychologist and specialist of physical activity, and defining detailed protocol of intervention
  • Kasch Pulse Recovery Test
  • determination of hs-C-reactive protein, Interleukin 6, chemerin and adiponectin concentrations in blood samples obtained during screening
  • informing parents about the objectives and protocol of the study
  • obtaining written informed consent for participation in the study
  • randomization to GROUP I or II
  • densitometry (DXA) - within one week after enrollment

Visit II: after 13 weeks:

  • medical history, physical examination
  • anthropometric evaluation and analysis of body composition (bioimpedance method)
  • consultation of dietician, psychologist and specialist of physical activity, and defining detailed protocol of intervention

Within a week prior to Visit III - obtaining blood (ca. 5 ml) for laboratory testing (complete blood count, lipid profile, hs-C-reactive protein, oral glucose tolerance test, insulin, Interleukin 6, adiponectin and chemerin concentrations

Visit III: after 26 weeks:

  • medical history, physical examination
  • interpretation of laboratory findings
  • anthropometric evaluation and analysis of body composition (bioimpedance method)
  • consultation of dietician, psychologist and specialist of physical activity, and defining detailed protocol of intervention
  • obtaining blood for laboratory testing
  • termination of active compound/placebo administration

Visit IV: after 52 weeks:

  • medical history, physical examination
  • anthropometric evaluation and analysis of body composition (bioimpedance method)
  • consultation of dietician, psychologist and specialist of physical activity, and defining detailed protocol of intervention
  • densitometry (DXA) - within one week after terminating the study
Conditions
Obesity
Being tested
Vitamin D 1200 IU, Placebo
Keywords
obesity, weight loss, vitamin D deficiency, body composition
Medical subject headings
Obesity, Weight Loss, Vitamin D Deficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vitamin D 1200 IUDrug

    Also called cholecalciferol

    Vitamin D 1200 IU once a day for 26 weeks

  • PlaceboDrug

    placebo once a day for 26 weeks

Study groups in NCT02828228
Study groupRoleWhat they receive
Vitamin D 1200 IUExperimentalSupplementation with vitamin D (1200 IU) once a day for 26 weeks
Receives: Drug: Vitamin D 1200 IU
PlaceboPlacebo comparatorPlacebo once a day for 26 weeks
Receives: Drug: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone mineral density

    Increase in bone mineral density during weight-loss program and vitamin D supplementation

    Measured: 12 months

Secondary outcomes (7)
  1. Blood level of vitamin D

    Changes in blood level of vitamin D after supplementation

    Measured: 12 months

  2. Arterial blood pressure

    Change in blood pressure afer weight-loss and vitamin D supplementation

    Measured: 12 months

  3. Lipid profile

    Change of lipid profile after weight-loss and vitamin D supplementation

    Measured: 12 months

  4. Oral Glucose Tolerance Test

    Change of biochemical parameters after weight-loss and vitamin D supplementation

    Measured: 12 months

  5. Chemerin

    Change in chemerin level

    Measured: 12 months

  6. BMI (kg/m2)

    Change of BMI during 12-months weight loss-program and supplementation of vitamin D

    Measured: 12 months

  7. Fat mass (kg)

    Change in fat free mass during 12-months weight-loss programme and supplementation of vitamin D

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2016 (estimated)
  2. Study startFeb 2016
  3. Primary completionFeb 2018 (estimated)
  4. Study completionFeb 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02828228
Sponsor's protocol ID
01/2016/UCK
Status last verified
Jul 2016
First submitted
8 Jun 2016
Last updated
11 Jul 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes

Publications

  • Szlagatys-Sidorkiewicz A, Brzezinski M, Jankowska A, Metelska P, Slominska-Fraczek M, Socha P. Long-term effects of vitamin D supplementation in vitamin D deficient obese children participating in an integrated weight-loss programme (a double-blind placebo-controlled study) - rationale for the study design. BMC Pediatr. 2017 Apr 4;17(1):97. doi: 10.1186/s12887-017-0851-7.

    PubMed 28376768

Questions about this trial

What is this clinical trial studying?

A study testing Vitamin D 1200 IU in people with Obesity, run by University Clinical Centre, Gdansk at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Magdalena Słominska-Frączek, MD, (694844420, fraczek@gumed.edu.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone mineral density (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02828228, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in